Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I

被引:1
|
作者
Can, Ngoc Thi Bich [1 ]
Tran, Dien Minh [1 ]
Bui, Thao Phuong [1 ]
Nguyen, Khanh Ngoc [1 ]
Nguyen, Hoang Huy [2 ]
Nguyen, Tung Van [2 ]
Hwu, Wuh-Liang [3 ]
Tomatsu, Shunji [4 ]
Vu, Dung Chi [1 ]
机构
[1] Vietnam Natl Childrens Hosp, 18-879 Lathanh, Hanoi 100000, Vietnam
[2] Vietnam Acad Sci & Technol, Inst Genome Res, 18 Hoang Quoc Viet, Hanoi 100000, Vietnam
[3] Natl Taiwan Univ Hosp, Dept Pediat, 8 Chung Shan South Rd, Taipei 10041, Taiwan
[4] Nemours Alfred I duPont Hosp Children, DuPont Expt Stn, Bldg E400 5205,200 Powder Mill Rd, Wilmington, DE 19803 USA
来源
LIFE-BASEL | 2021年 / 11卷 / 11期
关键词
alpha-L-iduronidase (IDUA) gene; IDUA gene mutation; mucopolysaccharidosis type I; PRE-MESSENGER-RNA; IDENTIFICATION; MUTATIONS; PREDICTION; MANAGEMENT;
D O I
10.3390/life11111162
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder caused by deleterious mutations in the alpha-L-iduronidase (IDUA) gene. Until now, MPS I in Vietnamese has been poorly addressed. Five MPS I patients were studied with direct DNA sequencing using Illumina technology confirming pathogenic variants in the IDUA gene. Clinical characteristics, additional laboratory results, and family history were collected. All patients have presented with the classical characteristic of MPS I, and alpha-L-iduronidase activity was low with the accumulation of glycosaminoglycans. Three variants in the IDUA gene (c.1190-10C > A (Intronic), c.1046A > G (p.Asp349Gly), c.1862G > C (p.Arg621Pro) were identified. The c.1190-10C > A variant represents six of the ten disease alleles, indicating a founder effect for MPS I in the Vietnamese population. Using biochemical and genetic analyses, the precise incidence of MPS I in this population should accelerate early diagnosis, newborn screening, prognosis, and optimal treatment.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy
    Pereira, Vanessa Goncalves
    Martins, Ana Maria
    Micheletti, Cecilia
    D'Almeida, Vania
    CLINICA CHIMICA ACTA, 2008, 387 (1-2) : 75 - 79
  • [22] Mucopolysaccharidosis Type I Presenting with Persistent Neonatal Respiratory Distress: A Case Report
    Asseri, Ali Alsuheel
    Alzoani, Ahmad
    Almazkary, Abdulwahab M.
    Abdulaziz, Nisreen
    Almazkary, Mufareh H.
    Alahmari, Samy Ailan
    Duraisamy, Arul J.
    Sureshkumar, Shruti
    DISEASES, 2023, 11 (02)
  • [23] Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients
    Chkioua, Latifa
    Khedhiri, Souhir
    Ben Turkia, Hadhami
    Tcheng, Remy
    Froissart, Roseline
    Chahed, Henda
    Ferchichi, Salima
    Ben Dridi, Marie Francoise
    Vianey-Saban, Christine
    Laradi, Sandrine
    Miled, Abdelhedi
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [24] Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients
    Oussoren, Esmee
    Keulemans, Joke
    van Diggelen, Otto P.
    Oemardien, Linda V.
    Timmermans, Remco G.
    van der Ploeg, Ans T.
    Ruijter, George J. G.
    MOLECULAR GENETICS AND METABOLISM, 2013, 109 (04) : 377 - 381
  • [25] Newborn screening of mucopolysaccharidosis type I
    Donati, Maria Alice
    Pasquini, Elisabetta
    Spada, Marco
    Polo, Giulia
    Burlina, Alberto
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (04) : 257 - 277
  • [26] Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients
    Matte, U
    Yogalingam, G
    Brooks, D
    Leistner, S
    Schwartz, I
    Lima, L
    Norato, DY
    Brum, JM
    Beesley, C
    Winchester, B
    Giugliani, R
    Hopwood, JJ
    MOLECULAR GENETICS AND METABOLISM, 2003, 78 (01) : 37 - 43
  • [27] Molecular characterization of a large group of Mucopolysaccharidosis type IIIC patients reveals the evolutionary history of the disease
    Martins, Carla
    de Medeiros, Paula Frassinetti, V
    Leistner-Segal, Sandra
    Dridi, Larbi
    Elcioglu, Nursel
    Wood, Jill
    Behnam, Mandiyeh
    Noyan, Bilge
    Lacerda, Lucia
    Geraghty, Michael T.
    Labuda, Damian
    Giugliani, Roberto
    Pshezhetsky, Alexey, V
    HUMAN MUTATION, 2019, 40 (08) : 1084 - 1100
  • [28] A few challenges in mucopolysaccharidosis type I
    Bay, Luisa
    Amartino, Hernan
    Antacle, Alejandra
    Arberas, Claudia
    Berretta, Adriana
    Botto, Hugo
    Cazalas, Mariana
    Copiz, Adriana
    De Cunto, Carmen
    Drelichman, Guillermo
    Espada, Graciela
    Eiroa, Hernan
    Fainboim, Alejandro
    Fano, Virginia
    Guelber, Norberto
    Maffey, Alberto
    Parisi, Claudio
    Pereyra, Marcela
    Remondino, Rodrigo
    Schenone, Andrea
    Specola, Norma
    Staciuk, Raquel
    Zuccaro, Graciela
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2021, 119 (03): : E193 - E201
  • [29] Mucopolysaccharidosis Type I in the Russian Federation and Other Republics of the Former Soviet Union: Molecular Genetic Analysis and Epidemiology
    Voskoboeva, E. Yu
    Bookina, T. M.
    Semyachkina, A. N.
    Mikhaylova, S. V.
    Vashakmadze, N. D.
    Baydakova, G. V.
    Zakharova, E. Yu
    Kutsev, S. I.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 8
  • [30] Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature
    Gragnaniello, Vincenza
    Gueraldi, Daniela
    Rubert, Laura
    Manzoni, Francesca
    Cazzorla, Chiara
    Giuliani, Antonella
    Polo, Giulia
    Salviati, Leonardo
    Burlina, Alberto
    INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2020, 6 (04)